Kenya is among beneficiaries of Sh6.8 billion funding from a global medical solution company in a bid to reduce newborn mortality.
The money from Newborn Essential Solutions and Technologies (NEST360°) will be spread through an eight-year programme, which will see an upgrade in services, equipment and medical personnel who handle preterm babies.
This is also in a bid to upscale innovation of equipment suitable for the Kenyan market.
Some of the organisations that are part of the programme include the Bill and Melinda Gates Foundation, the ELMA Foundation, the Children’s Investment Fund Foundation, London School of Hygiene and Tropical Medicine.
SEE ALSO: Covid-19: Kenya records 447 new cases hitting record high
In Kenya, one out of every eight babies is born preterm.
NEST360° hopes to develop and deliver a package that will supply a bundle of affordable and robust medical devices to hospitals to help reduce the number of babies who die in the first month of life.
In Kenya, the project, which was rolled out on October 4, is jointly run by the Centre for Public Health and Development (CPHD) and Kenya Medical Research Institute’s Wellcome Trust Research Programme.
CPHD Executive Director David Adudans said they have seen, lived and talked about pre-term babies dying due to lack of expertise and equipment, which should not be so.
“This intervention is a game-changer as we shall not only be supplying equipment but also building capacity of the clinical and biomedical workforce,” Dr Adudans said.
SEE ALSO: Congo virus funds embezzled by 'mafia network', says deputy minister